Treatment Patterns and Key Endpoints Among Patients With Chronic-Phase Chronic Myeloid Leukemia in a Community Oncology Setting

Clinical trial NCT07374120 · COMPLETED

Trial details

NCT number: NCT07374120
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Leukemia, Myeloid, Chronic-Phase

Start date: 2024-02-01
Primary completion: 2025-01-21
Enrollment: 1480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.